REUTERS: The S&P 500 dropped on Tuesday as excitement over signs of a first successful late-stage COVID-19 vaccine trial faded, while investors continued to pull money out of the big tech companies that have benefited most from the pandemic.
Value-linked stocks, which tend to outperform coming out of a recession, added 4per cent, while growth stocks fell 0.6per cent. U.S. regulators on Monday also authorized emergency use of the first experimental antibody drug for COVID-19 developed by Eli Lilly & Co, pushing its shares up by 2.2per cent. At 9:54 a.m. ET, the Dow Jones Industrial Average was up 76.21 points, or 0.26per cent, at 29,234.18, the S&P 500 was down 14.28 points, or 0.40per cent, at 3,536.22. The Nasdaq Composite was down 141.57 points, or 1.21per cent, at 11,572.21.
United States United States Latest News, United States United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »